Aging, cytomegalovirus (CMV) and influenza vaccine responses

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Influenza vaccination is less effective in elderly as compared to young individuals. Several studies have identified immune biomarkers able to predict a protective humoral immune response to the vaccine. In this review, we summarize current knowledge on the effects of aging on influenza vaccine responses and on biomarkers so far identified, and we discuss the relevance of latent cytomegalovirus (CMV) infection on these vaccine responses.

Original languageEnglish (US)
Pages (from-to)682-690
Number of pages9
JournalHuman Vaccines and Immunotherapeutics
Issue number3
StatePublished - Mar 3 2016


  • Aging
  • B cells
  • CMV
  • influenza vaccine

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology


Dive into the research topics of 'Aging, cytomegalovirus (CMV) and influenza vaccine responses'. Together they form a unique fingerprint.

Cite this